Cardio Diagnostics (CDIO) Projected to Post Earnings on Wednesday

Cardio Diagnostics (NASDAQ:CDIO) is projected to release its earnings data before the market opens on Wednesday, May 14th. Analysts expect Cardio Diagnostics to post earnings of ($0.06) per share and revenue of $0.05 million for the quarter.

Cardio Diagnostics Stock Down 15.0%

Shares of CDIO stock opened at $0.16 on Tuesday. Cardio Diagnostics has a fifty-two week low of $4.50 and a fifty-two week high of $53.10. The stock’s 50-day moving average is $0.39 and its two-hundred day moving average is $0.51.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.